71
Views
16
CrossRef citations to date
0
Altmetric
Review

Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis

, &
Pages 299-310 | Published online: 10 May 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Min Jun Shin, Jun Young Park, Dae Ho Lee & Dongwoo Khang. (2021) Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis. International Journal of Nanomedicine 16, pages 8485-8507.
Read now
C. E. Vergunst, M. G. H. van de Sande, M. C. Lebre & P. P. Tak. (2005) The role of chemokines in rheumatoid arthritis and osteoarthritis. Scandinavian Journal of Rheumatology 34:6, pages 415-425.
Read now

Articles from other publishers (14)

Zoltán Szekanecz & Alisa E. Koch. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology 384 395.e5 .
Victor Fattori, Flavio A. Amaral & Waldiceu A. VerriJr.Jr.. (2016) Neutrophils and arthritis: Role in disease and pharmacological perspectives. Pharmacological Research 112, pages 84-98.
Crossref
Mohammad Hosein Farzaei, Fatemeh Farzaei, Mohammad Abdollahi, Zahra Abbasabadi, Amir Hossein Abdolghaffari & Bahman Mehraban. (2016) A mechanistic review on medicinal plants used for rheumatoid arthritis in traditional Persian medicine. Journal of Pharmacy and Pharmacology 68:10, pages 1233-1248.
Crossref
Zoltán Szekanecz & Alisa E. Koch. (2015) Successes and failures of chemokine-pathway targeting in rheumatoid arthritis. Nature Reviews Rheumatology 12:1, pages 5-13.
Crossref
Francesca Garello, Francesca Arena, Juan Carlos Cutrin, Giovanna Esposito, Luca D'Angeli, Federico Cesano, Miriam Filippi, Sara Figueiredo & Enzo Terreno. (2015) Glucan particles loaded with a NIRF agent for imaging monocytes/macrophages recruitment in a mouse model of rheumatoid arthritis. RSC Adv. 5:43, pages 34078-34087.
Crossref
Gaurav Malviya, Simonetta Salemi, Bruno Laganà, Andrea Picchianti Diamanti, Raffaele D’Amelio & Alberto Signore. (2013) Biological Therapies for Rheumatoid Arthritis: Progress to Date. BioDrugs 27:4, pages 329-345.
Crossref
Shivaprasad H. Venkatesha, Brian Astry, Siddaraju M. Nanjundaiah, Hua Yu & Kamal D. Moudgil. (2012) Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines. Bioorganic & Medicinal Chemistry 20:17, pages 5229-5234.
Crossref
Joanna Z Peng, David E GutsteinLisa Beck, Lisa Hickey, Carolyn M Hustad, Smita Abbi, Ajay Nirula, Julie DeMartino, Paul Rothenberg, Keith Gottesdiener, Daniel M Bloomfield & John A Wagner. (2012) Quantifying monocyte infiltration in response to intradermal tetanus toxoid injection. Biomarkers in Medicine 6:4, pages 541-551.
Crossref
Siddaraju M. Nanjundaiah, David Y.-W. Lee, Zhongze Ma, Harry H. S. Fong, Lixing Lao, Brian M. Berman & Kamal D. Moudgil. (2012) Modified Huo-Luo-Xiao-Ling Dan Suppresses Adjuvant Arthritis by Inhibiting Chemokines and Matrix-Degrading Enzymes. Evidence-Based Complementary and Alternative Medicine 2012, pages 1-8.
Crossref
J. Smolen & D. Aletaha. (2007) The burden of rheumatoid arthritis and access to treatment: a medical overview. The European Journal of Health Economics 8:S2, pages 39-47.
Crossref
Josef S Smolen, Daniel Aletaha, Marcus Koeller, Michael H Weisman & Paul Emery. (2007) New therapies for treatment of rheumatoid arthritis. The Lancet 370:9602, pages 1861-1874.
Crossref
Takanori Akagi, Masae Suzuki, Takahiro Sato & Takanori Ichiki. (2007) On-Chip Evaluation of Damage on Cell Surfaces Induced by Cell Dissociation Agents. Japanese Journal of Applied Physics 46:9S, pages 6404.
Crossref
Paul P. Tak. (2006) Chemokine inhibition in inflammatory arthritis. Best Practice & Research Clinical Rheumatology 20:5, pages 929-939.
Crossref
Jasper J. Haringman, Danielle M. Gerlag, Tom J. M. Smeets, Dominique Baeten, Filip van den Bosch, Barry Bresnihan, Ferdinand C. Breedveld, Huib J. Dinant, Francois Legay, Hermann Gram, Pius Loetscher, Robert Schmouder, Thasia Woodworth & Paul P. Tak. (2006) A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis & Rheumatism 54:8, pages 2387-2392.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.